東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

PTSD symptom severity and neurocogni...

Seagly, Katharine Surella.

FindBook

Google Book

Amazon

博客來

PTSD symptom severity and neurocognitive performance as a function of combined TMS and imaginal exposure in OIF/OEF combat veterans with treatment resistant PTSD.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	PTSD symptom severity and neurocognitive performance as a function of combined TMS and imaginal exposure in OIF/OEF combat veterans with treatment resistant PTSD./
作者:	Seagly, Katharine Surella.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2015,
面頁冊數:	117 p.
附註:	Source: Dissertation Abstracts International, Volume: 77-03(E), Section: B.
Contained By:	Dissertation Abstracts International77-03B(E).
標題:	Clinical psychology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3726289
ISBN:	9781339109619

PTSD symptom severity and neurocognitive performance as a function of combined TMS and imaginal exposure in OIF/OEF combat veterans with treatment resistant PTSD.
Seagly, Katharine Surella.

PTSD symptom severity and neurocognitive performance as a function of combined TMS and imaginal exposure in OIF/OEF combat veterans with treatment resistant PTSD. - Ann Arbor : ProQuest Dissertations & Theses, 2015 - 117 p.

Source: Dissertation Abstracts International, Volume: 77-03(E), Section: B.

Thesis (Ph.D.)--Old Dominion University, 2015.

Posttraumatic Stress Disorder (PTSD) is a commonly occurring mental health diagnosis, and is particularly prevalent in combat veterans. Although there has been some success treating PTSD with various forms of therapy, many cases remain refractory to the current standard of care. This pilot study combines transcranial magnetic stimulation (TMS) to the right dorsolateral prefrontal cortex (DLPFC) and the supplementary motor area (SMA) with a standardized exposure protocol for the treatment of chronic, treatment-resistant PTSD. The aims are to (1) determine if the treatment is safe and well tolerated, (2) determine if PTSD and concomitant depression and anxiety symptoms improve, and (3) determine if executive functioning and memory improve. Results indicated the treatment was safe and well tolerated, and improvements were seen across psychological symptoms. Neurocognitively, improvements were seen in executive functioning but not in non-executive memory. Statistically significant results must be interpreted with caution due to the likelihood of sampling error associated with a small sample size. However, clinical results were striking, with six of the seven participants no longer meeting criteria for PTSD by the end of the study. Clinical results for this pilot study were promising and warrant further investigation with larger sample sizes utilizing a RCT model to confirm and expand upon these preliminary findings.

ISBN: 9781339109619Subjects--Topical Terms:

524863
Clinical psychology.

PTSD symptom severity and neurocognitive performance as a function of combined TMS and imaginal exposure in OIF/OEF combat veterans with treatment resistant PTSD.
LDR:02452nmm a2200301 4500 001 2117187
005 20170509115855.5
008 180830s2015 ||||||||||||||||| ||eng d
020 $a 9781339109619
035 $a (MiAaPQ)AAI3726289
035 $a AAI3726289
040 $a MiAaPQ $c MiAaPQ
100 1 $a Seagly, Katharine Surella. $3 3278944
245 1 0 $a PTSD symptom severity and neurocognitive performance as a function of combined TMS and imaginal exposure in OIF/OEF combat veterans with treatment resistant PTSD.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2015
300 $a 117 p.
500 $a Source: Dissertation Abstracts International, Volume: 77-03(E), Section: B.
500 $a Adviser: Serina A. Neumann.
502 $a Thesis (Ph.D.)--Old Dominion University, 2015.
520 $a Posttraumatic Stress Disorder (PTSD) is a commonly occurring mental health diagnosis, and is particularly prevalent in combat veterans. Although there has been some success treating PTSD with various forms of therapy, many cases remain refractory to the current standard of care. This pilot study combines transcranial magnetic stimulation (TMS) to the right dorsolateral prefrontal cortex (DLPFC) and the supplementary motor area (SMA) with a standardized exposure protocol for the treatment of chronic, treatment-resistant PTSD. The aims are to (1) determine if the treatment is safe and well tolerated, (2) determine if PTSD and concomitant depression and anxiety symptoms improve, and (3) determine if executive functioning and memory improve. Results indicated the treatment was safe and well tolerated, and improvements were seen across psychological symptoms. Neurocognitively, improvements were seen in executive functioning but not in non-executive memory. Statistically significant results must be interpreted with caution due to the likelihood of sampling error associated with a small sample size. However, clinical results were striking, with six of the seven participants no longer meeting criteria for PTSD by the end of the study. Clinical results for this pilot study were promising and warrant further investigation with larger sample sizes utilizing a RCT model to confirm and expand upon these preliminary findings.
590 $a School code: 0418.
650 4 $a Clinical psychology. $3 524863
650 4 $a Medicine. $3 641104
650 4 $a Mental health. $3 534751
690 $a 0622
690 $a 0564
690 $a 0347
710 2 $a Old Dominion University. $b Psychology. $3 3278945
773 0 $t Dissertation Abstracts International $g 77-03B(E).
790 $a 0418
791 $a Ph.D.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3726289